🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
59,53 USD
Máx. histórico
2.925,00
12010 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,96%
Rango 52 semanas
37,06 – 95,49
Variación hoy
-0,07%
Cierre anterior
59,57
Rango de hoy
59,25 – 60,89
Volumen hoy
1.327.132
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,88%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 20 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/04/2023 | 25,38 | 25,86 | 25,12 | 25,56 | +0,63% | 2,92% | 856.600 |
| 31/03/2023 | 24,59 | 25,56 | 24,43 | 25,40 | +3,97% | 4,60% | 1.184.500 |
| 30/03/2023 | 24,88 | 24,94 | 24,05 | 24,43 | -1,25% | 3,58% | 697.200 |
| 29/03/2023 | 24,52 | 24,78 | 24,14 | 24,74 | +1,98% | 2,62% | 754.400 |
| 28/03/2023 | 24,25 | 24,59 | 24,12 | 24,26 | -0,70% | 1,94% | 697.900 |
| 27/03/2023 | 24,34 | 24,81 | 24,09 | 24,43 | +0,58% | 2,96% | 1.046.800 |
| 24/03/2023 | 23,95 | 24,33 | 23,09 | 24,29 | +2,58% | 5,18% | 846.700 |
| 23/03/2023 | 23,97 | 24,40 | 23,50 | 23,68 | -0,17% | 3,75% | 958.800 |
| 22/03/2023 | 24,54 | 24,89 | 23,68 | 23,72 | -3,58% | 4,91% | 1.068.000 |
| 21/03/2023 | 25,10 | 25,50 | 24,56 | 24,60 | -1,84% | 3,73% | 969.800 |
| 20/03/2023 | 24,39 | 25,87 | 24,33 | 25,06 | +3,13% | 6,31% | 1.423.900 |
| 17/03/2023 | 24,34 | 24,39 | 23,09 | 24,30 | -0,57% | 5,34% | 2.395.100 |
| 16/03/2023 | 25,12 | 25,26 | 24,19 | 24,44 | -3,48% | 4,24% | 2.229.000 |
| 15/03/2023 | 26,76 | 26,76 | 24,75 | 25,32 | -4,67% | 7,49% | 2.017.800 |
| 14/03/2023 | 26,99 | 27,87 | 26,25 | 26,56 | +0,53% | 6,00% | 1.388.300 |
| 13/03/2023 | 26,04 | 26,93 | 25,70 | 26,42 | +0,42% | 4,72% | 2.752.700 |
| 10/03/2023 | 27,59 | 27,68 | 25,54 | 26,31 | -5,12% | 7,76% | 2.064.700 |
| 09/03/2023 | 29,68 | 29,90 | 27,60 | 27,73 | -6,51% | 7,75% | 1.750.400 |
| 08/03/2023 | 30,50 | 30,70 | 29,20 | 29,66 | -2,75% | 4,90% | 1.175.100 |
| 07/03/2023 | 30,62 | 31,07 | 30,22 | 30,50 | -0,94% | 2,78% | 940.600 |
| 06/03/2023 | 32,44 | 32,68 | 30,33 | 30,79 | -4,82% | 7,23% | 1.288.100 |
| 03/03/2023 | 32,57 | 33,15 | 32,16 | 32,35 | -0,25% | 3,04% | 1.172.800 |
| 02/03/2023 | 32,28 | 32,84 | 31,51 | 32,43 | -0,70% | 4,12% | 1.084.000 |
| 01/03/2023 | 32,45 | 32,84 | 32,40 | 32,66 | +1,11% | 1,36% | 1.126.000 |
| 28/02/2023 | 32,45 | 33,12 | 32,28 | 32,30 | -0,92% | 2,59% | 924.600 |
| 27/02/2023 | 33,05 | 33,17 | 32,34 | 32,60 | -0,09% | 2,51% | 682.300 |
| 24/02/2023 | 32,10 | 32,85 | 32,10 | 32,63 | -0,37% | 2,34% | 866.000 |
| 23/02/2023 | 32,90 | 33,07 | 32,52 | 32,75 | -0,30% | 1,69% | 666.000 |
| 22/02/2023 | 31,83 | 32,95 | 31,78 | 32,85 | +3,40% | 3,69% | 772.500 |
| 21/02/2023 | 33,00 | 33,28 | 31,29 | 31,77 | -5,87% | 6,03% | 897.500 |